Loading...

Major Indexes

Financial Statements

Selecta Biosciences Inc.

Selecta Biosciences Inc. (SELB)

$3.67
-0.01 (-0.27%)

Income Statement

Download SELB income statement Download SELB income statement Download SELB income statement
Year 2019 2018 2017 2016 2015 2014
Earnings Per Share Basic -7.84-15.13-3.89-3.20-2.92-1.22
Net Profit Margin ---4.48-315.56-72.35-8.29
Earnings Per Share Diluted -7.84-15.13-3.89-3.20-2.92-1.22
Revenue --8.080.210.906.68
Weighted Average Shares Outstanding -8.5110.4920.4322.3945.55
Gross Profit --8.080.210.906.68
Weighted Average Shares Outstanding (Diluted) 2.092.1510.4920.4322.3945.55
Sales, General and Administrative Expense 7.958.3413.0518.8318.2416.39
Dividend per Share ------
Operating Income -18.44-31.32-34.67-63.78-65.02-52.45
Gross Margin --1.001.001.001.00
Earnings before Tax -12.88-25.17-36.21-65.32-65.34-55.35
EBITDA Margin ---4.21-305.64-70.79-7.53
Net Income -12.88-25.17-36.21-65.32-65.34-55.35
EBIT Margin ---4.29-308.14-72.01-7.86
Net Income - Discounted ops ------
Profit Margin ---4.48-315.56-72.35-8.29
Preferred Dividends 3.497.33----
Free Cash Flow margin ---0.00-0.00-0.00-0.00
R&D Expenses 10.4922.9829.7045.1647.6942.74
Interest Expense 0.550.951.251.211.491.52
Earnings Before Tax Margin ------
Consolidated Income -12.88-25.17-36.21-65.32-65.34-55.35
EBIT -12.33-24.23-34.67-63.78-65.02-52.45
EBITDA -11.46-23.18-34.06-63.27-63.92-50.30
Income Tax Expense ------
Operating Expenses 18.4431.3242.7563.9965.9259.13
Cost of Revenue ------
Net Income Com -12.88-25.17-36.21-65.32-65.34-55.35
Net Income - Non-Controlling int ------

Balance Sheet Statement

Download SELB balance shet statement Download SELB balance sheet statement Download SELB balance sheet statement
Year 2019 2018 2017 2016 2015 2014
Total current liabilities 9.237.2913.7110.9735.1434.94
Other Liabilities 6.305.110.220.15-26.87
Long-term debt 4.8211.867.9821.04--
Cash and cash equivalents 18.9432.7958.6670.62-89.89
Total debt 7.4011.8612.0421.0421.390.37
Cash and short-term investments 18.9436.9184.1496.56-89.89
Deferred revenue 4.383.611.840.790.961.67
Inventories ------
Tax Liabilities ------
Goodwill and Intangible Assets ------
Deposit Liabilities ------
Tax assets ------
Total non-current liabilities 6.7214.5420.4238.1614.7629.36
Total current assets 19.1138.9186.8298.6842.0896.67
Total liabilities 15.9521.8434.3449.2949.9091.17
Payables 0.352.183.881.611.100.50
Other comprehensive income -3.88-4.99211.07273.13279.54348.71
Short-term investments -4.1325.4825.94--
Retained earnings (deficit) -83.88-111.51-151.60-216.90-280.40-335.80
Property, Plant & Equipment Net 1.982.032.052.092.131.22
Total non-current assets 3.123.912.482.422.412.90
Other Assets -0.501.18----
Net Debt -11.54-25.06-46.61-49.5821.39-89.52
Investments -4.1325.4825.94--
Total shareholders equity -87.75-116.4954.9651.81-5.428.40
Total assets 22.2342.8289.30101.1044.4899.57
Long-term investments ------
Receivables 0.670.820.210.06-5.00
Short-term debt 2.58-4.07-21.390.37

Cash Flow Statement

Download SELB cash flow statement Download SELB cash flow statement Download SELB cash flow statement
Year 2019 2018 2017 2016 2015 2014
Insurance (repayment) of debt ------
Net Cash/Marketcap 0.000.00----
Insurance (buybacks) of shares ------
Depreciation & Amortization 0.861.040.610.521.102.15
Dividend payments ------
Operating Cash Flow -12.69-22.46-19.68-52.04-59.16-51.44
Acquisitions and disposals ------
Free Cash Flow -12.91-23.63-20.27-52.77-60.05-51.48
Net cash flow / Change in cash 8.5415.7426.3211.97-33.3453.87
Effect of forex changes on cash -3.32-1.020.440.08-0.150.03
Financing Cash Flow 24.7743.9167.6666.020.70105.04
Investment purchases and sales --3.52----
Capital Expenditure -0.23-1.160.590.730.880.05
Stock-based compensation 1.221.132.054.085.715.16
Investing Cash Flow ------

Retained Earning Schedule

Year 2019 2018 2017 2016 2015 2014
Retained Earnings (Previous Year) --84-112-152-217-280
Net Income -13-25-36-65-65-55
Stock Dividends -71-2-402-0
Dividend Paid ------
Retained Earnings -84-112-152-217-280-336

PPE Schedule

Year 2019 2018 2017 2016 2015 2014
Gross PPE -22222
Annual Depreciation 21-1-1-1-1
Capital Expenditure -0-11110
Net PPE 222221

Intangible and Goodwill Schedule

Year 2019 2018 2017 2016 2015 2014
Intangible and Goodwill (Previous Year) ------
New Purchases --4----
Intangible and Goodwill ------

Selecta Biosciences Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Selecta Biosciences Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.